Cassandra Buto-Colletti
Advanced Heart Failure and Transplant Cardiology · Columbia, SCNPI 1174563597
Payments from drug & device makers
What this record shows
This record is dominated by grants: $15,000 of the $20,913 with a category attached, or 71.7%. Medtronic accounts for 75.0% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $18,264 and has fallen 98.4% since, to $298 in 2025.
Across 146 payments — averaging $143.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Abbott$3K
- Novartis$520
- Pfizer$237
- Boehringer Ingelheim$213
- AstraZeneca$210
- plus $1K from 15 others
What the payments were for
- Grants$15,00072%
- Travel & lodging$1,6548%
- Food & beverage$4,06219%
- Education$1971%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $15,678 |
| Abbott | 44 | $3,031 |
| Novartis | 24 | $520 |
| Pfizer | 13 | $237 |
| Boehringer Ingelheim | 10 | $213 |
| AstraZeneca | 8 | $210 |
| Actelion Pharmaceuticals US, Inc. | 6 | $209 |
| Abiomed | 3 | $180 |
| Boston Scientific | 2 | $90 |
| Merck | 6 | $90 |
| Cvrx, Inc. | 4 | $88 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $83 |
| E.r. Squibb & Sons, L.L.C. | 4 | $68 |
| Sanofi | 1 | $65 |
| Philips North America LLC | 2 | $38 |
| Bayer | 2 | $27 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Amgen | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Endotronix, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HeartWare HVAD$15,000
- HeartMate PHP$1,350
- HeartMate 3 Left Ventricular Dev$293
- HeartMate$289
- MitraClip System$191
- UPTRAVI$124
- OPSUMIT$124
- ENTRESTO$110
- FARXIGA$102
How this compares
$20,913 in reported general payments places this provider in the 60th percentile of 30 advanced heart failure and transplant cardiology providers in South Carolina.
See all advanced heart failure and transplant cardiology providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 43 | $53,371 |
| FarxigaDapagliflozin Propanediol | 32 | $31,532 |
| JardianceEmpagliflozin | 27 | $24,745 |
| EliquisApixaban | 19 | $14,309 |
| Carvedilol | 37 | $229 |
| Spironolactone | 39 | $223 |
| Metoprolol Succinate | 20 | $168 |
| Atorvastatin Calcium | 13 | $130 |
| Furosemide | 14 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $520 | $53,37143 claims |
| AstraZenecaFarxiga | $210 | $31,53232 claims |
| Boehringer IngelheimJardiance | $213 | $24,74527 claims |
| PfizerEliquis | $237 | $14,30919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 30 advanced heart failure and transplant cardiology providers in South Carolina.
Other advanced heart failure and transplant cardiology in Columbia
- Patrick McCannColumbia$579K
- James AmpaduColumbia$131K
- Joshua ConeyColumbia$14K
- Barry FeldmanColumbia$12K
- Rebecca NapierColumbia$12K
- Michael RofaelColumbia$11K
- Ryan TedfordCharleston$528K
- Michael ZileCharleston$358K
- Anil PurohitWest Columbia$172K
- Daniel JudgeCharleston$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.